These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 782693)

  • 21. Chemistry and structure-activity studies of the nitrosoureas.
    Montgomery JA
    Cancer Treat Rep; 1976 Jun; 60(6):651-64. PubMed ID: 954007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides.
    Gugova R; Topakbashian V; Lozeva S; Dimov S; Golovinsky E
    Drugs Exp Clin Res; 1997; 23(2):71-5. PubMed ID: 9309382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The biochemical mechanisms of drug resistance to N-alkyl-N-nitrosoureas and derivatives of cis-dichlorodiammineplatinum].
    Gorbacheva LB
    Vopr Onkol; 1995; 41(2):50-1. PubMed ID: 7483435
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitative structure-activity relationships of antineoplastic drugs: nitrosoureas and triazenoimidazoles.
    Hansch C; Smith N; Engle R; Wood H
    Cancer Chemother Rep; 1972 Aug; 56(4):443-56. PubMed ID: 5081587
    [No Abstract]   [Full Text] [Related]  

  • 25. [Different sensitivity of DNA synthesis in normal and tumor cells to exposure to several N-alkyl-N-nitrosoureas].
    Sokolova IS; Kukushkina GV; Gorbacheva LB
    Dokl Akad Nauk SSSR; 1979; 245(1):260-4. PubMed ID: 155515
    [No Abstract]   [Full Text] [Related]  

  • 26. L1210 leukemia i.v. implanted as a model for testing short-chain nitrosourea analogs.
    Schmid JR; Fiebig HH; Eisenbrand G; Löhr GW
    J Cancer Res Clin Oncol; 1986; 111(1):31-4. PubMed ID: 3949848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Frei E; Schabel FM; Goldin A
    Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
    [No Abstract]   [Full Text] [Related]  

  • 28. Structure-activity relationships: nitrosoureas.
    Johnston TP
    Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
    Mori KJ; Jasmin C; Hayat M; MacDonald JS; Mathé G
    Cancer Res; 1980 Nov; 40(11):4282-6. PubMed ID: 6451285
    [No Abstract]   [Full Text] [Related]  

  • 30. Synergistic antileukemic activity of combinations of two nitrosoureas.
    Wheeler GP; Schabel FM; Trader MW
    Cancer Treat Rep; 1981; 65(7-8):591-9. PubMed ID: 6454482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
    Zackheim HS; Epstein EH
    Arch Dermatol; 1975 Dec; 111(12):1564-70. PubMed ID: 1200661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of structure and chemical activity on the ability of nitrosoureas to inhibit DNA repair.
    Kann HE; Schott MA; Petkas A
    Cancer Res; 1980 Jan; 40(1):50-5. PubMed ID: 6444211
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo DNA damage and resistance to 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in L1210 leukemia cells.
    Gorbacheva LB; Kukushkina GV; Durdeva AD; Ponomarenko NA
    Neoplasma; 1988; 35(1):3-14. PubMed ID: 3127736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
    Montgomery JA; McCaleb GS; Johnston TP; Mayo JG; Laster WR
    J Med Chem; 1977 Feb; 20(2):291-5. PubMed ID: 836501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry (VI)].
    Miyahara M; Kamiya S; Nakadate M; Sueyoshi S; Tanno M; Miyahara M
    Eisei Shikenjo Hokoku; 1982; (100):163-5. PubMed ID: 7183380
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and study of spin-labeled nitrosoureas.
    Raikov Z; Todorov D; Ilarionova M; Demirov G; Tsanova T; Kafalieva D
    Cancer Biochem Biophys; 1985 Feb; 7(4):343-8. PubMed ID: 2983881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitrosoureas in central nervous system tumors.
    Walker MD
    Cancer Chemother Rep 3; 1973 May; 4(3):21-6. PubMed ID: 4584033
    [No Abstract]   [Full Text] [Related]  

  • 38. Nitrosoureas: important new drugs for the treatment of cancer.
    Salmon SE
    Ariz Med; 1976 Feb; 33(2):102-4. PubMed ID: 1275737
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S; Ogawa M; Sakurai Y
    Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
    [No Abstract]   [Full Text] [Related]  

  • 40. The oncostatic and immunosuppressive action of new nitrosourea derivatives containing sugar radicals.
    Imbach JL; Montero JL; Moruzzi A; Serrou B; Chenu E; Hayat M; Mathe G
    Biomedicine; 1975 Dec; 23(10):410-3. PubMed ID: 1222217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.